Ï㽶ÊÓƵ

Dr.ÌýZogopoulos’ lab studies the genetics and oncogenomics of pancreaticobiliary cancers. His research includes discovery of genetic associations with familial pancreatic cancer, and therapeutic opportunities for pancreaticobiliary cancers driven by homologous recombination deficiency.

To pursue his research interests, Dr.ÌýZogopoulosÌýestablished and directs the Quebec Pancreas Cancer Study (QPCS), a familial patient registry and biospecimen repository for pancreatic, biliary tract and peri-ampullary malignancies. His program’s resources also include patient-derived tumour xenograft and cell-line libraries.

His translational research program is integrated into the ambulatory oncology clinics at the Ï㽶ÊÓƵ Health Centre to facilitate access to genetic counseling and testing as well as precision oncology and early detection opportunities for patients with pancreaticobiliary cancers.

Dr.ÌýZogopoulosÌýis the Pancreatic Disease Oriented Group co-Chair of the Canadian Cancer Trials Group (CCTG), and his research activities also include theÌýpan-CanadianÌýPancreatic Cancer Profiling for Individualized Care (EPPIC) study, theÌýQuebec Consortium for Novel Cancer Therapeutics and Biomarkers, theÌýPancreatic Cancer Genetic Epidemiology (PACGENE) consortium, and the Pancreatic Cancer Early Detection (PRECEDE) consortium.

His clinical practice focuses on the surgical treatment of pancreatic, biliary and hepatic malignancies, as well as abdominal organ transplantation with a focus on transplant oncology.Ìý